Cannabis business news, every Tuesday.

DEA Moves to Deny Medical Cannabis Registrations in 6 States and D.C.

DEA orders to show cause now reach medical cannabis applicants in California, Illinois, Oregon, Delaware, North Dakota and D.C., on top of Minnesota.

Federal Hemp Ban Phase 1: THC-O and Other Synthetics Are No Longer Hemp

Starting Nov. 12, hemp products with cannabinoids the plant can’t make naturally, like THC-O, lose federal hemp status. The wider ban is set for Dec. 11.

Cannabis Banking: 16 Governors Push Congress to Pass SAFE Banking Act

Sixteen governors asked congressional leaders on Nov. 9 to pass the SAFE Banking Act before this Congress ends, citing cash-related robbery risks.

Illinois Hemp Act Enforcement Paused for 250 Businesses Until Nov. 19

Illinois won’t enforce its Hemp Act against about 250 businesses in a federal lawsuit until Nov. 19. For every other seller, the 0.4 mg limit starts Nov. 12.

California Cannabis Pesticide Tests Find Chemicals the State Doesn’t Screen

LA Times lab tests of 49 legal products found new hazardous chemicals in about 1 in 4, and California’s screening list won’t grow until April 2028.

DEA Keeps 2027 Marijuana Production Quotas Flat, Schedule III Pending

DEA’s proposed 2027 quotas hold Schedule I marijuana at 6,675 kg and leave limits for state medical marijuana in Schedule III to a later notice.